These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 4154993

  • 1. The effect of beta-phenethylamine on noradrenaline and dopamine turnover in rat brain.
    Jackson DM, Smythe DB.
    J Pharm Pharmacol; 1974 Jun; 26(6):456-8. PubMed ID: 4154993
    [No Abstract] [Full Text] [Related]

  • 2. Antinociceptive action of oxotremorine and regional turnover of rat brain noradrenaline, dopamine and 5-HT.
    Paalzow G, Paalzow L.
    Eur J Pharmacol; 1975 Apr; 31(2):261-72. PubMed ID: 238855
    [Abstract] [Full Text] [Related]

  • 3. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
    Jonsson G, Lohmander S, Sachs C.
    Biochem Pharmacol; 1974 Sep 15; 23(18):2585-93. PubMed ID: 4153539
    [No Abstract] [Full Text] [Related]

  • 4. The effect of beta-phenethylamine on noradrenaline concentrations in guinea-pig brain.
    Jackson DM.
    J Pharm Pharmacol; 1971 Aug 15; 23(8):623-4. PubMed ID: 4397748
    [No Abstract] [Full Text] [Related]

  • 5. The relative functional availability of brain noradrenaline and dopamine storage pools.
    McMillen BA, Shore PA.
    J Pharm Pharmacol; 1977 Dec 15; 29(12):780-1. PubMed ID: 22634
    [No Abstract] [Full Text] [Related]

  • 6. The effects of some hallucinogenic drugs upon the metabolism of noradrenaline.
    Leonard BE, Tonge SR.
    Life Sci; 1969 Aug 01; 8(15):815-25. PubMed ID: 5807314
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC, Healy MD.
    Fed Proc; 1976 Dec 01; 35(14):2558-62. PubMed ID: 11134
    [No Abstract] [Full Text] [Related]

  • 8. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH, Davis WM.
    J Pharmacol Exp Ther; 1977 Jul 01; 202(1):182-91. PubMed ID: 17725
    [No Abstract] [Full Text] [Related]

  • 9. Interaction of beta-phenethylamine with dopamine and noradrenaline in the central nervous system of the rat.
    Baker GB, Raiteri M, Bertollini A, del Carmine R.
    J Pharm Pharmacol; 1976 May 01; 28(5):456-7. PubMed ID: 6762
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of the novel antipsychotic agent remoxipride on dopamine and noradrenaline turnover in the rat brain.
    Magnusson O, Fowler CJ.
    Pharmacol Toxicol; 1989 Oct 01; 65(4):295-8. PubMed ID: 2573899
    [Abstract] [Full Text] [Related]

  • 11. Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5-hydroxytryptamine.
    Peringer E, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1975 Jun 01; 27(6):442-4. PubMed ID: 237096
    [No Abstract] [Full Text] [Related]

  • 12. Clonidine reverses baclofen-induced increases in noradrenaline turnover in rat brain.
    Sawynok J, Reid A.
    Neurochem Res; 1986 May 01; 11(5):723-31. PubMed ID: 2873522
    [Abstract] [Full Text] [Related]

  • 13. Evidence of a role for brain monoamines in ethanol dependence.
    Griffiths PJ, Littleton JM, Oritz A, Brownlee G.
    Br J Pharmacol; 1973 Jun 01; 48(2):354P. PubMed ID: 4147432
    [No Abstract] [Full Text] [Related]

  • 14. Effect of des-Tyr1-gamma-endorphin and des-Tyr1-alpha-endorphin on alpha-MPT-induced catecholamine disappearance in rat brain nuclei: a dose--response study.
    Versteeg DH, Kovács GL, Bohus B, de Kloet ER, de Wied D.
    Brain Res; 1982 Jan 14; 231(2):343-51. PubMed ID: 6120024
    [Abstract] [Full Text] [Related]

  • 15. Passive avoidance performance correlates with catecholamine turnover in discrete limbic brain regions.
    Kovács GL, Versteeg DH, de Kloet ER, Bohus B.
    Life Sci; 1981 Mar 09; 28(10):1109-16. PubMed ID: 6112649
    [No Abstract] [Full Text] [Related]

  • 16. The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover.
    Clark WG, Corrodi H, Masuoka DT.
    Eur J Pharmacol; 1971 Jun 09; 15(1):41-4. PubMed ID: 5161339
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of the turnover of the brain dopamine after treatment with the gammaaminobutyrate: 2-oxyglutarate transaminase inhibitor aminooxyacetic acid.
    Andén NE.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Jun 09; 283(4):419-24. PubMed ID: 4278500
    [No Abstract] [Full Text] [Related]

  • 18. Neuropeptide Y alters monoamine turnover in the rat brain.
    Vallejo M, Carter DA, Biswas S, Lightman SL.
    Neurosci Lett; 1987 Jan 14; 73(2):155-60. PubMed ID: 3822247
    [Abstract] [Full Text] [Related]

  • 19. Actions of atropine, hemicholinium-3, and physostigmine on chlorpromazine-induced changes in rat brain monoamines.
    Bhatnagar SP.
    Can J Physiol Pharmacol; 1974 Jun 14; 52(3):500-7. PubMed ID: 4152758
    [No Abstract] [Full Text] [Related]

  • 20. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
    Lidbrink P, Corrodi H, Fuxe K, Olson L.
    Brain Res; 1972 Oct 27; 45(2):507-24. PubMed ID: 4404488
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.